Plasmid DNA encoding influenza virus haemagglutinin induces Th 1 cells and protection against respiratory infection despite its limited ability to generate antibody responses

Journal of General Virology

Volumn 81, Issue 7, 2000, Pages 1737-1745

  Johnson, Patricia A ^a   Conway, Margaret A ^a   Daly, Janet ^b   Nicolson, Carolyn ^b   Robertson, James ^b   Mills, Kingston H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN G; INACTIVATED VACCINE; INTERLEUKIN 5; PLASMID DNA; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC CODE; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFECTION; SPLEEN CELL;

ANIMALIA; DNA VIRUSES; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0033916526     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-7-1737     Document Type: Article

References (28)

1. Bot, A., Antohi, S., Bot, S., Garcia-Sastre, A. & Bono, C. (1997). Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. International Immunology 9, 1641-1650.
2. Brazolot Millan, C. L., Weeratna, R., Krieg, A. M., Siegrist, C. A. & Davis, H. L. (1998). CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proceedings of the National Academy of Sciences, USA 95, 15553-15558.
3. Casares, S., Inaba, K., Brumeanu, T. D., Steinman, R. M. & Bona, C. A. (1997). Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. Journal of Experimental Medicine 186, 1481-1486.
4. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. & Harding, C. V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. Journal of Experimental Medicine 186, 1623-1631.
5. Davis, H. L. (1998). Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proceedings of the National Academy of Sciences, USA 95, 12631-12636.
6. Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J. & Krieg, A. M. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Journal of Immunology 160, 870-876.
7. Deck, R. R., Corrille, M., DeWitt, J. J., Liu, M. A. & Ulmer, J. B. (1997). Characterization of humoral immune responses induced by influenza hemagglutinin DNA vaccine. Vaccine 15, 71-78.
8. Donnelly, J. J. (1997). DNA vaccines. Annual Reviews in Immunology 15, 617-648.
9. Feltquate, D. M., Heaney, S., Webster, R. G. & Robinson, H. L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. Journal of Immunology 158, 2278-2284.
10. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C. & Robinson, H. L. (1993). DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proceedings of the National Academy of Sciences, USA 90, 11478-11482.
11. Graham, M. B. & Braciale, T. J. (1997). Resistance to recovery from lethal influenza virus infection in B lymphocyte-deficient mice. Journal of Experimental Medicine 186, 2063-2068.
12. b, d, k). Journal of Immunology 161, 1094-1103.
13. Hawkes, R. A. (1979). General principles underlying laboratory diagnosis of viral infections. In Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, pp. 34-35. Edited by E. H. Lennette & N. J. Schmidt. Washington, DC: American Public Health Association.
14. Klinman, D. M. (1998). Therapeutic applications of CpG-containing oligodeoxynucleotides. Antisense Nucleic Acid and Drug Development 8, 181-184.
15. Klinman, D. M., Yamshchikov, G. & Ishigatsubo, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. Journal of Immunology 158, 3635-3639.
16. Krieg, A. M., Yi, A. K., Schorr, J. & Davis, H. L. (1998). The role of CpG dinucleotides in DNA vaccines. Trends in Microbiology 6, 23-27.
17. Liu, M. A. (1995). Overview of DNA vaccines. Annals of the New York Academy of Science 772, 15-20.
18. Mills, K. H. G., Skehel, J. J., Graham, C. M. & Thomas, D. B. (1986). Extensive diversity in the recognition of influenza virus haemagglutinin by murine T cell clones. Journal of Experimental Medicine 163, 1477-1490.
19. Mills, K. H. G., Ryan, M., Ryan, E. & Mahon, B. P. (1998). A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infection and Immunity 66, 594-602.
20. + Th1 cells by immunization with recombinant gp120 entrapped in biodegradable microparticles. Vaccine 13, 1741-1749.
21. Moore, A., McCarthy, L. & Mills, K. H. G. (1999). The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a recombinant HIV protein from Th2 to Th1. Vaccine 17, 2517-2527.
22. Robinson, H. L. & Torres, C. A. (1997). DNA vaccines. Seminars in Immunology 9, 271-283.
23. Topham, D. J., Tripp, R. A., Hamilton-Easton, A. M., Sara, S. R. & Doherty, P. C. (1996). Quantitative analysis of the influenza virus-specific CD4 + T cell memory in the absence of B cells and Ig. Journal of Immunology 157, 2947-2952.
24. Torres, C. A., Iwasaki, A., Barber, B. H. & Robinson, H. L. (1997). Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. Journal of Immunology 158, 4529-4532.
25. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. I., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C., Friedman, A., Hawe, K. R., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L. & Liu, M. A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1748-1749.
26. Ulmer, J. B., Deck, R. R., DeWitt, C. M., Friedman, A., Donnelly, J. J. & Liu, M. A. (1994). Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541-1544.
27. Webster, R. G. (1999). Potential advantages of DNA immunization for influenza epidemic and pandemic planning. Clinical Infectious Diseases 28, 225-229.
28. Webster, R. G., Fynan, E. F., Santoro, J. C. & Robinson, H. (1994). Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12, 1495-1498.